Emerging Middle EAST Primary Biliary Cholangitis Therapeutics Market Trends Shaping Industry Growth Worldwide
The Middle EAST Primary Biliary Cholangitis Therapeutics Market was valued at USD 0.25 billion in 2024 and is projected to reach USD 0.55 billion by 2034, registering a CAGR of 8.5%. This growth trajectory is underpinned by several factors, including the rising prevalence of primary biliary cholangitis (PBC), increasing awareness of the disease, and advancements in therapeutic options. The...
0 Commentaires 0 Parts 71 Vue 0 Aperçu
Moundo https://moundo.social